Skip to main content

Douglas Ward

Personal Genome Diagnostics has appointed Douglas Ward as CEO and a member of the board of directors. Ward joins PGDx from Roche, where he most recently served as VP of companion diagnostics for Ventana Medical Systems, a Roche subsidiary. Prior to his work at Roche, he served as president and general manager of commercial operations for GE Healthcare's Life Sciences business in the Americas. Before that, he held positions of increasing responsibility at Bayer Healthcare, including country head for UK and Ireland, and VP of marketing and scientific affairs for Bayer Molecular Diagnostics.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.